Keywords: Opioid painkillers, FDA action, Label changes, USA

US doctors, researchers and health officials want FDA action to deter mis-prescribing of opioid painkillers

Article | 26 July 2012

Labels on opioid pain medications should be revised to prevent overprescribing, a broad coalition of doctors, researchers and public health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in